Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate in Women of Childbearing Age – MarketWatch

April 29, 2014 2:15 pm

http://www.marketwatch.com/story/novavax-announces-positive-top-line-data-from-dose-confirmatory-phase-2-clinical-trial-of-its-rsv-vaccine-candidate-in-women-of-childbearing-age-2014-04-28?reflink=MW_news_stmp

Leave a Reply

Your email address will not be published. Required fields are marked *


*

Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now